Journals / Türk Nöroşirürji Dergsi / 2017 / Cilt: 27 - Sayı: 3

Molecular Genetics in Craniosynostosis

Kraniosinostozda Moleküler Genetik

Pages
239–244
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The problem of postoperative reclosure of calvarial sutures will hopefully be solved in the near future

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The molecular genetics of craniosynostosis has become an important topic in the last 20 years.
📊
Key Findings & Data:There are 60 gene mutations that have been proven to cause these pathologies in syndromic and nonsyndromic craniosynostosis.
💡
Conclusion & Impact:The problem of postoperative reclosure of calvarial sutures will hopefully be solved in the near future
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The molecular genetics of craniosynostosis has become an important topic in the last 20 years. Detailed genetic mechanisms related to the development and early closure of calvarial sutures have been described. Many genetic pathways have been reported to play a role in this process. There are 60 gene mutations that have been proven to cause these pathologies in syndromic and nonsyndromic craniosynostosis. The treatment for craniosynostosis is surgery at present. The main aim is not to solve the cosmetic problems but to decrease intracranial pressure and it has been shown that neuromotor development is less affected afterwards. The mortality rate of such surgery is 1.5-2%. New therapeutic methods will help manage these gene mutations and decrease surgical morbidity. The problem of postoperative reclosure of calvarial sutures will hopefully be solved in the near future

Özet

Kraniosinostozların moleküler genetiği ile ilgili çalışmalar son 20 yılda önem kazanmıştır. Kalvarial sütürlerin gelişimi ve erken kapanması ile ilgili oldukça detaylı genetik mekanizmalar gösterilmiştir. Çok sayıda yolağın bu süreçte rol oynadığı ortaya konmuştur. Nonsendromik ve sendromik kraniosinostozlarda 60'a yakın gen mutasyonunun bu patolojilere neden olduğu ispatlanmıştır. Günümüzde kraniosinostozların primer tedavisi cerrahidir. Asıl amaç kozmetik nedenler değil mevcut intrakranial basıncın azaltılması ve çocuğun nöromotor gelişiminin zarar görmeden devam etmesidir. Bu majör cerrahilerin mortalitesi %1,5-2 aralığındadır. Önümüzdeki yıllarda bu gen mutasyonları üzerine etkili olabilecek yeni terapötik yöntemler ile cerrahi morbiditeyi azaltmak ve postoperatif süreçte tekrar sütür kapanmasını önlemek esas hedef olacaktır

🔖

Cite This Article

BAŞARIR, M. (2022). Molecular Genetics in Craniosynostosis. Türk Nöroşirürji Dergsi, Cilt: 27 - Sayı: 3, 239–244. https://ajindex.com/articles/637386

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Baird LC, Proctor MR: Craniosynostosis. In: Albright AL, Pollack IF, Adelson PD (eds). Principles and Practice of Pediatric Neurosurgery, üçüncü baskı. New York: Thieme, 2015:237-248 2. Bialek P, Kern B, Yang X, Schrock M, Sosic D, Hong N, Wu H, Yu K, Ornitz DM, Olson EN, Justice MJ, Karsenty G: A twist code determines the onset of osteoblast differentiation. Dev Cell 6:423-435, 2004 3. Boulet SL, Rasmussen SA, Honein MA: A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A 146A:984-991, 2008 4. Cooper GM, Curry C, Barbano TE, Burrows AM, Vecchione L, Caccamese JF, Norbutt CS, Costello BJ, Losee JE, Moursi AM, Huard J, Mooney MP: Noggin inhibits postoperative resynostosis in craniosynostotic rabbits. J Bone Miner Res 22:1046-1054, 2007 5. Cooper GM, Usas A, Olshanski A, Mooney MP, Losee JE, Huard J: Ex vivo Noggin gene therapy inhibits bone formation in a mouse model of postoperative resynostosis. Plast Reconstr Surg 123:94S-103S, 2009 6. Cunningham ML, Horst JA, Rieder MJ, Hing AV, Stanaway IB, Park SS, Samudrala R, Speltz ML: IGF1R variants associated with isolated single suture craniosynostosis. Am J Med Genet A 155A:91-97, 2011 7. Deckelbaum RA, Holmes G, Zhao Z, Tong C, Basilico C, Loomis CA: Regulation of cranial morphogenesis and cell fate at the neural crest-mesoderm boundary by engrailed 1. Development 139:1346-1358, 2012 8. Eswarakumar VP, Lax I, Schlessinger J: Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139-149, 2005 9. Fluck CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, Jabs EW, Mendonça BB, Fujieda K, Miller WL: Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36:228-230, 2004 10. Greenwald JA, Mehrara BJ, Spector JA, Warren SM, Fagenholz PJ, Smith LE, Bouletreau PJ, Crisera FE, Ueno H, Longaker MT: In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol 158:441-452, 2001 11. Hwang SK, Park KS, Park SH, Hwang SK: Update of diagnostic evaluation of craniosynostosis with a focus on pediatric systematic evaluation and genetic studies. J Korean Neurosurg Soc 59:214-218, 2016 12. Iseki S, Wilkie AO, Morriss-Kay GM: Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126:5611-5620, 1999 13. Jiang X, Iseki S, Maxson RE, Sucov HM, Morriss-Kay GM: Tissue origins and interactions in the m